Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older.
Eric L SimpsonAmy S PallerElaine C SiegfriedDiamant ThaçiAndreas WollenbergMichael J CorkDanielle MarcouxRui HuangZhen ChenAna B RossiBrad ShumelDebra SierkaAshish BansalPublished in: Dermatology and therapy (2021)
LIBERTY AD ADOL (NCT03054428) and LIBERTY AD PEDS (NCT03345914). Does dupilumab provide improvement in atopic dermatitis across all anatomical regions in children and adolescents? (MP4 48,385 kb).